Quipt Home Medical Corp. (QIPT)
USD 2.2
(-2.22%)
USD 2.2
(-2.22%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 148.66 Million USD | 67.32% |
| 2022 | 88.85 Million USD | 31.55% |
| 2021 | 67.54 Million USD | 43.26% |
| 2020 | 47.14 Million CAD | 17.75% |
| 2019 | 40.04 Million CAD | -3.56% |
| 2018 | 41.51 Million CAD | 0.71% |
| 2017 | 41.22 Million CAD | -50.44% |
| 2016 | 83.19 Million CAD | 120.68% |
| 2015 | 37.69 Million CAD | 207.2% |
| 2014 | 12.27 Million CAD | 449.09% |
| 2013 | 2.23 Million CAD | 7.49% |
| 2012 | 2.07 Million CAD | 43.69% |
| 2011 | 1.44 Million CAD | -14.3% |
| 2010 | 1.68 Million CAD | 513.58% |
| 2009 | 275.17 Thousand CAD | -50.5% |
| 2008 | 555.87 Thousand CAD | -24.69% |
| 2007 | 738.11 Thousand CAD | -29.45% |
| 2006 | 1.04 Million CAD | 26.66% |
| 2005 | 825.96 Thousand CAD | -76.1% |
| 2004 | 3.45 Million CAD | 46.85% |
| 2003 | 2.35 Million CAD | 28.95% |
| 2002 | 1.82 Million CAD | 23.29% |
| 2001 | 1.48 Million CAD | 224.17% |
| 2000 | 456.67 Thousand CAD | 0.0% |
| 1999 | - CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 33.94 Million USD | -5.64% |
| 2024 Q3 | 33.71 Million USD | 9.36% |
| 2024 Q1 | 34.49 Million USD | 7.78% |
| 2023 FY | 148.66 Million USD | 67.32% |
| 2023 Q3 | 41.11 Million USD | 6.6% |
| 2023 Q4 | 42.15 Million USD | 2.52% |
| 2023 Q2 | 38.57 Million USD | 43.79% |
| 2023 Q1 | 26.82 Million USD | 2.87% |
| 2022 Q4 | 26.07 Million USD | 10.43% |
| 2022 Q1 | 20.53 Million USD | -6.87% |
| 2022 FY | 88.85 Million USD | 31.55% |
| 2022 Q2 | 18.62 Million USD | -9.32% |
| 2022 Q3 | 23.61 Million USD | 26.81% |
| 2021 FY | 67.54 Million USD | 43.26% |
| 2021 Q2 | 14.47 Million USD | 13.38% |
| 2021 Q3 | 17.86 Million USD | 23.42% |
| 2021 Q4 | 22.05 Million USD | 23.43% |
| 2021 Q1 | 12.76 Million USD | -2.52% |
| 2020 Q4 | 13.09 Million CAD | 13.67% |
| 2020 FY | 47.14 Million CAD | 17.75% |
| 2020 Q2 | 10.83 Million CAD | -8.11% |
| 2020 Q1 | 11.78 Million CAD | 29.87% |
| 2020 Q3 | 11.52 Million CAD | 6.37% |
| 2019 Q1 | 10.14 Million CAD | 2.44% |
| 2019 Q2 | 9.99 Million CAD | -1.4% |
| 2019 FY | 40.04 Million CAD | -3.56% |
| 2019 Q3 | 10.26 Million CAD | 2.62% |
| 2019 Q4 | 9.07 Million CAD | -11.53% |
| 2018 Q3 | 10.32 Million CAD | -6.25% |
| 2018 Q4 | 9.89 Million CAD | -4.17% |
| 2018 FY | 41.51 Million CAD | 0.71% |
| 2018 Q1 | 10.95 Million CAD | 183.59% |
| 2018 Q2 | 11.01 Million CAD | 0.58% |
| 2017 Q4 | -13.1 Million CAD | -164.9% |
| 2017 Q1 | 17.31 Million CAD | -3.77% |
| 2017 Q3 | 20.19 Million CAD | 27.42% |
| 2017 FY | 41.22 Million CAD | -50.44% |
| 2017 Q2 | 15.84 Million CAD | -8.48% |
| 2016 Q3 | 20.69 Million CAD | -18.32% |
| 2016 Q1 | 20.06 Million CAD | 38.34% |
| 2016 FY | 83.19 Million CAD | 120.68% |
| 2016 Q4 | 17.99 Million CAD | -13.06% |
| 2016 Q2 | 25.33 Million CAD | 26.28% |
| 2015 FY | 37.69 Million CAD | 207.2% |
| 2015 Q2 | 5.57 Million CAD | 6.27% |
| 2015 Q4 | 14.5 Million CAD | 15.23% |
| 2015 Q3 | 12.58 Million CAD | 125.68% |
| 2015 Q1 | 5.24 Million CAD | -30.15% |
| 2014 Q4 | 7.51 Million CAD | 226.44% |
| 2014 FY | 12.27 Million CAD | 449.09% |
| 2014 Q3 | 2.3 Million CAD | 45.78% |
| 2014 Q1 | 816.21 Thousand CAD | 33.46% |
| 2014 Q2 | 1.57 Million CAD | 93.44% |
| 2013 Q2 | 528.84 Thousand CAD | -14.49% |
| 2013 Q4 | 611.59 Thousand CAD | 16.02% |
| 2013 FY | 2.23 Million CAD | 7.49% |
| 2013 Q3 | 527.14 Thousand CAD | -0.32% |
| 2013 Q1 | 618.47 Thousand CAD | 15.2% |
| 2012 Q2 | 527.71 Thousand CAD | 21.96% |
| 2012 Q4 | 536.87 Thousand CAD | -8.24% |
| 2012 Q3 | 585.11 Thousand CAD | 10.88% |
| 2012 FY | 2.07 Million CAD | 43.69% |
| 2012 Q1 | 432.7 Thousand CAD | 25.43% |
| 2011 Q3 | 436.65 Thousand CAD | 20.03% |
| 2011 FY | 1.44 Million CAD | -14.3% |
| 2011 Q1 | 290.84 Thousand CAD | -66.31% |
| 2011 Q2 | 363.77 Thousand CAD | 25.08% |
| 2011 Q4 | 344.98 Thousand CAD | -20.99% |
| 2010 Q4 | 863.27 Thousand CAD | 5.06% |
| 2010 Q1 | 31.91 Thousand CAD | 988.24% |
| 2010 Q2 | 18.44 Thousand CAD | -42.2% |
| 2010 FY | 1.68 Million CAD | 513.58% |
| 2010 Q3 | 821.7 Thousand CAD | 4354.88% |
| 2009 FY | 275.17 Thousand CAD | -50.5% |
| 2009 Q4 | -3592.48 CAD | -105.34% |
| 2009 Q3 | 67.33 Thousand CAD | 86.58% |
| 2009 Q2 | 36.08 Thousand CAD | -35.52% |
| 2009 Q1 | 55.96 Thousand CAD | -60.18% |
| 2008 Q3 | -1.9 Million CAD | -330.37% |
| 2008 Q2 | 828.92 Thousand CAD | -5.63% |
| 2008 Q1 | 878.33 Thousand CAD | 382.56% |
| 2008 FY | 555.87 Thousand CAD | -24.69% |
| 2008 Q4 | 140.53 Thousand CAD | 107.36% |
| 2007 FY | 738.11 Thousand CAD | -29.45% |
| 2007 Q4 | 182.01 Thousand CAD | 113.6% |
| 2007 Q3 | -1.33 Million CAD | -290.42% |
| 2007 Q2 | 703.01 Thousand CAD | -1.57% |
| 2007 Q1 | 714.2 Thousand CAD | 348.04% |
| 2006 FY | 1.04 Million CAD | 26.66% |
| 2006 Q2 | 700.96 Thousand CAD | -21.58% |
| 2006 Q1 | 893.79 Thousand CAD | 566.47% |
| 2006 Q3 | -1.22 Million CAD | -275.4% |
| 2006 Q4 | 159.4 Thousand CAD | 112.97% |
| 2005 FY | 825.96 Thousand CAD | -76.1% |
| 2005 Q1 | 812.96 Thousand CAD | -13.44% |
| 2005 Q2 | 734.44 Thousand CAD | -9.66% |
| 2005 Q3 | -1.69 Million CAD | -330.86% |
| 2005 Q4 | 134.1 Thousand CAD | 107.91% |
| 2004 Q2 | 984.94 Thousand CAD | 8.67% |
| 2004 Q3 | 956.95 Thousand CAD | -2.84% |
| 2004 Q4 | 939.16 Thousand CAD | -1.86% |
| 2004 FY | 3.45 Million CAD | 46.85% |
| 2004 Q1 | 906.33 Thousand CAD | 426.39% |
| 2003 Q1 | 478.65 Thousand CAD | 281.53% |
| 2003 FY | 2.35 Million CAD | 28.95% |
| 2003 Q4 | 172.18 Thousand CAD | -78.76% |
| 2003 Q3 | 810.68 Thousand CAD | 53.74% |
| 2003 Q2 | 527.32 Thousand CAD | 10.17% |
| 2002 Q1 | 430.35 Thousand CAD | -1.81% |
| 2002 FY | 1.82 Million CAD | 23.29% |
| 2002 Q3 | 541.17 Thousand CAD | 28.55% |
| 2002 Q4 | 125.45 Thousand CAD | -76.82% |
| 2002 Q2 | 420.97 Thousand CAD | -2.18% |
| 2001 Q4 | 438.29 Thousand CAD | 0.0% |
| 2001 FY | 1.48 Million CAD | 224.17% |
| 2000 FY | 456.67 Thousand CAD | 0.0% |
| 1999 FY | - CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1224.546% |
| Cerus Corporation | 143.15 Million USD | -3.85% |
| OrthoPediatrics Corp. | 137.01 Million USD | -8.501% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1208.589% |
| Talis Biomedical Corporation | 67.18 Million USD | -121.277% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -495.955% |
| Inogen, Inc. | 236.08 Million USD | 37.028% |
| Spectral AI, Inc. | 20.86 Million USD | -612.553% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -165.491% |
| CVRx, Inc. | 76.14 Million USD | -95.25% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -4113.922% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1090.384% |
| Orthofix Medical Inc. | 667.42 Million USD | 77.725% |
| Venus Concept Inc. | 80.47 Million USD | -84.735% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -162.765% |
| Bioventus Inc. | 409.91 Million USD | 63.733% |
| BrainsWay Ltd. | 28.01 Million USD | -430.612% |
| Envoy Medical, Inc. | 17.89 Million USD | -730.635% |
| electroCore, Inc. | 32.03 Million USD | -364.135% |
| IceCure Medical Ltd | 16.87 Million USD | -780.937% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -250.365% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -743.117% |
| MaxCyte, Inc. | 84.84 Million USD | -75.222% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1097.791% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2471.49% |
| PAVmed Inc | 64.82 Million USD | -129.329% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -191.059% |
| RxSight, Inc. | 103.85 Million USD | -43.156% |
| Sight Sciences, Inc. | 126.44 Million USD | -17.571% |
| SI-BONE, Inc. | 156.35 Million USD | 4.915% |
| TELA Bio, Inc. | 84.18 Million USD | -76.591% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -112.212% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 26.896% |
| LivaNova PLC | 843.54 Million USD | 82.376% |
| 908 Devices Inc. | 68.08 Million USD | -118.371% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 69.258% |
| Nemaura Medical Inc. | 7.13 Million USD | -1982.52% |
| NeuroPace, Inc. | 75.29 Million USD | -97.443% |
| LENSAR, Inc. | 33.33 Million USD | -345.965% |
| Apyx Medical Corporation | 51.01 Million USD | -191.401% |
| Cutera, Inc. | 197.72 Million USD | 24.811% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -499.923% |
| BioSig Technologies, Inc. | 28.53 Million USD | -421.09% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 22.357% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -312.277% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 82.225% |
| Axonics, Inc. | 270.2 Million USD | 44.979% |
| Outset Medical, Inc. | 198.77 Million USD | 25.207% |
| IRIDEX Corporation | 31.81 Million USD | -367.301% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 17.508% |
| IRadimed Corporation | 30.12 Million USD | -393.536% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1642.464% |
| INVO Bioscience, Inc. | 7.85 Million USD | -1793.053% |
| Telesis Bio, Inc. | 63.48 Million USD | -134.162% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -51.003% |
| Varex Imaging Corporation | 224.8 Million USD | 33.867% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1168.165% |
| Pulmonx Corporation | 112.68 Million USD | -31.929% |
| Dynatronics Corporation | 9.9 Million USD | -1400.47% |
| Modular Medical, Inc. | 17.52 Million USD | -748.12% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -636.449% |
| Semler Scientific, Inc. | 38.94 Million USD | -281.746% |
| InMode Ltd. | 215.68 Million USD | 31.071% |
| Bruker Corporation | 1.07 Billion USD | 86.188% |
| Cytosorbents Corporation | 48.33 Million USD | -207.565% |
| DexCom, Inc. | 1.69 Billion USD | 91.209% |
| Align Technology, Inc. | 2.07 Billion USD | 92.842% |
| Viveve Medical, Inc. | 22.17 Million USD | -570.487% |
| ZimVie Inc. | 275.12 Million USD | 45.964% |
| Movano Inc. | 29.69 Million USD | -400.731% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -8.302% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2471.49% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -4113.922% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 75.26% |
| Profound Medical Corp. | 33.6 Million USD | -342.42% |
| Insulet Corporation | 939.9 Million USD | 84.183% |
| enVVeno Medical Corporation | 25.23 Million USD | -489.06% |
| Surmodics, Inc. | 98.69 Million USD | -50.63% |
| iCAD, Inc. | 22.22 Million USD | -568.918% |
| Nuwellis, Inc. | 22.61 Million USD | -557.44% |
| Biotricity, Inc. | 17.18 Million USD | -765.12% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 66.658% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1110.889% |
| InspireMD, Inc. | 22.95 Million USD | -547.786% |
| PAVmed Inc. | 64.82 Million USD | -129.329% |
| BIOLASE, Inc. | 34.66 Million USD | -328.917% |
| Beyond Air, Inc. | 61.7 Million USD | -140.951% |
| FONAR Corporation | 28.6 Million USD | -419.73% |
| AxoGen, Inc. | 149.33 Million USD | 0.448% |
| Vivani Medical, Inc. | 26.96 Million USD | -451.333% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 16.051% |
| Inari Medical, Inc. | 448.59 Million USD | 66.859% |
| UFP Technologies, Inc. | 58.08 Million USD | -155.93% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -2917.027% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2252.963% |
| Tenon Medical, Inc. | 16.96 Million USD | -776.161% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1910.916% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -237.092% |
| AdaptHealth Corp. | 1.07 Billion USD | 86.209% |
| Sintx Technologies, Inc. | 15.2 Million USD | -878.008% |
| NanoVibronix, Inc. | 4.97 Million USD | -2889.483% |
| Quanterix Corporation | 118.1 Million USD | -25.882% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1168.165% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -929.407% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 62.139% |
| TransMedics Group, Inc. | 182.82 Million USD | 18.681% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -429.724% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1239.471% |
| Hyperfine, Inc. | 52.87 Million USD | -181.183% |
| Establishment Labs Holdings Inc. | 172 Million USD | 13.567% |
| Biomerica, Inc. | 6.97 Million USD | -2030.51% |
| Bone Biologics Corporation | 9.42 Million USD | -1476.816% |
| AVITA Medical, Inc. | 80.77 Million USD | -84.041% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1341.799% |
| Silk Road Medical, Inc | 186.35 Million USD | 20.225% |